Loading…
ColLABorate 2025
American Society for Clinical Laboratory - Iowa (ASCLS-IA) is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.

https://ceorganizer.ascls.org/
Type: CH: Chemistry/Immunology clear filter
Tuesday, April 15
 

9:45am CDT

Navigating the Data Landscape: Practical Applications of Analytics in the Clinical Laboratory
Tuesday April 15, 2025 9:45am - 10:45am CDT
This  session will first provide an overview of data analytics in laboratory medicine and how it can be used to improve quality and efficiency within the clinical laboratory. We will then illustrate the utility of various data analytics tools using real-world examples of data-driven quality improvement initiatives in clinical chemistry, urinalysis, coagulation, and toxicology. Finally, we will discuss practical considerations for successful data analytics projects.
Learning Objectives:
  1. Describe three data analytics applications in the clinical laboratory
  2. Compare and contrast two different tools for data analytics
  3. List a common pitfall in data analytics projects and a strategy for avoiding it
Speakers
avatar for Anna E. Merrill, PhD, DABCC

Anna E. Merrill, PhD, DABCC

Co-Director of Clinical Chemistry, Clinical Associate Professor of Pathology, University of Iowa
Dr. Anna Merrill is Clinical Associate Professor of Pathology at the University of Iowa, where she directs clinical chemistry and coagulation.  She also oversees the clinical toxicology laboratory at the Iowa City VA Medical Center.  Her research interests include data-driven quality... Read More →
Tuesday April 15, 2025 9:45am - 10:45am CDT
Ballroom B&C
  CH: Chemistry/Immunology

3:00pm CDT

Traumatic Brain Injury Test: Novel Biomarkers for Mild Traumatic Brain Injury can Reduce the Need for Head CT
Tuesday April 15, 2025 3:00pm - 4:00pm CDT
This presentation will provide an overview of mild Traumatic Brain Injury (TBI), its assessment in the Emergency Department (ED), relevant biomarkers, clinical guidelines, practical applications of TBI biomarkers, and evaluation of TBI tests in the United States
Learning Objectives:
  1. Define mild Traumatic Brain Injury (TBI) and describe its impact on patients.
  2. Identify different biomarkers for TBI
  3. Explain how biomarkers for TBI can be utilized in clinical practice.
Speakers
avatar for Maureen Rabbitte, RN

Maureen Rabbitte, RN

Medical Science Liaison, Abbott
Maureen Rabbitte is a nurse scientist and medical science liaison for Abbott Labs. She specializes in public health, women's and adolescent health, and clinical education. Maureen is passionate about enhancing healthcare through innovative teaching and impactful research, with extensive... Read More →
Tuesday April 15, 2025 3:00pm - 4:00pm CDT
Ballroom A
  CH: Chemistry/Immunology
 
Wednesday, April 16
 

10:30am CDT

Drug Testing: Principles and Pitfalls
Wednesday April 16, 2025 10:30am - 11:30am CDT
Drug testing is commonly performed for medical care as well as for workplace and forensic purposes.  The most common specimen for routine drug testing is urine, although saliva (oral fluid) has been increasing in popularity.  Specimens used in more specialized situations include blood, hair, umbilical cord tissue, meconium, and sweat.  Challenges with drug testing arise with both screening and confirmatory tests.  Screening tests are vulnerable to false positives and false negatives.  Clinicians ordering testing may not be appear of limitations of drug screens or what compounds cross-reacts with a particular screen.  Confirmatory testing provides more definitive results, but interpretation of test results can be challenging.  Less commonly used specimens (e.g., hair, umbilical cord, meconium) have their own strengths and challenges.  The purpose of this session is to provide an overview of drug testing and illustrate key information that can help guide test selection and interpretation.  Illustrative cases will be interspersed throughout the session.
Learning Objectives:
  1. Define the limitations of drug of abuse screening assays including false positives
  2. Distinguish between screening and confirmatory tests for drug testing
  3. Explain the common specimens used for drug of abuse testing (urine, blood, oral fluid, hair, meconium, umbilical cord)
Speakers
avatar for Matthew D. Krasowski, MD, PhD

Matthew D. Krasowski, MD, PhD

Clinical Professor, University of Iowa Health Care
Matthew D. Krasowski, MD, PhD is a clinical pathologist and the Walter L. Bierring Professor of Clinical Education at the University of Iowa Hospitals and Clinics.  He currently serves as the Associate Residency Program Director and the Vice Chair of Clinical Pathology and Laboratory... Read More →
Wednesday April 16, 2025 10:30am - 11:30am CDT
Ballroom A
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.